Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
Phenothiazines / sumatriptan / Compazine
 
Attending: ___.
 
Chief Complaint:
Morbid Obesity
 
Major Surgical or Invasive Procedure:
___ laparoscopic sleeve gastrectomy

 
History of Present Illness:
Per Dr. ___: 

___ is a ___ female referred for the
evaluation of gastric restrictive surgery in the treatment and
management of morbid obesity by her primary care provider ___ of ___ in ___. 

___ was seen and evaluated in our ___ clinic on ___ and ___.

___ has class II severe obesity with weight of 196.6 pounds
as of ___ with her initial screen weight of 200.6 pounds on
___, height of 60.5 inches and BMI of 37.8.  Her previous
weight loss efforts have included Weight Watchers, Nutrisystem,
HMR ___ visits and M.D. supervision with Dr. ___ treated with prescription weight loss medication
Belviq.  She has been able to lose up to 15 pounds but her 
weight
loss efforts have failed to produce significant and/or lasting
results.  She stated that her lowest adult weight was 135 pounds
at the age of ___ and her highest weight was her initial 
screen
weight of 200.6 pounds.  She weighed 147 pounds in ___, 298
pounds ___ years ago, 295 pounds in ___ and 200 pounds one year
ago.  She stated that she has been struggling with weight since 
___
years ago and cites as factors contributing to her excess weight
large portions, too many carbohydrates and saturated fats,
grazing, night-time eating and lack of exercise although she
tries to walk about 3 miles per day as measured by her FitBit. 
She denied history of eating disorders - no anorexia, bulimia,
diuretic or laxative abuse and she is not a binge eater.  She
does have anxiety but does not have a clinical diagnosis of
depression except for reactive and situational and she is not
followed by a therapist nor has she been hospitalized for mental
health issues and she is not on any psychotropic medications.

 
Past Medical History:
Morbid Obesity
Type II Diabetes Mellitus not on Insulin: HbA1c 7.0
Papillary Thyroid Carcinoma s/p Total Thyroidectomy ___
Hypertriglyceridemia not on medications
Hypothyroidism
OSA on CPAP
Hepatic Steatosis on US
Asymptomatic Cholelithiasis 
Migraine HA
Open Angle Glaucoma
OA
 
Social History:
___
Family History:
Her family history is noted for father deceased age ___ with 
multiple myeloma and
history of stroke; mother living with type 2 diabetes,
hypertension and thyroid disorder; sister living with history of
rheumatoid arthritis.
 
Physical Exam:
VS: within normal limits
 GEN: AA&O x 3, NAD, calm, cooperative.  
 HEENT: (-)LAD, mucous membranes moist, trachea midline, EOMI  
 CHEST: Clear to auscultation bilaterally, (-) cyanosis.  
 ABDOMEN: soft, diffuse tenderness, incision sites are c/d/i 
covered with steri-strips  
 EXTREMITIES: Warm, well perfused, no edema  

 
Pertinent Results:
___ 05:30AM BLOOD Hct-37.1
___ 02:16PM BLOOD Hct-37.8
 
Brief Hospital Course:
The patient presented to pre-op on ___. Patient was evaluated 
by anaesthesia.  
 The patient was taken to the operating room for a laparoscopic 
sleeve gastrectomy for obesity. There were no adverse events in 
the operating room; please see the operative note for details. 
Patient was extubated, taken to the PACU until stable, then 
transferred to the ward for observation.
  
 Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA. Pain was 
very well controlled. The patient was then transitioned to 
crushed oral pain medication once tolerating a stage 3 diet.  

 CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.  

 Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization.  

 GI/GU/FEN: The patient was initially kept NPO. On POD 1 the 
patient had an upper GI series which revealed no leak. As a 
result, the patient was started on a stage 1 bariatric diet, 
which the patient tolerated well. Subsequently, the patient was 
advanced to stage 2, and then stage 3 diet which the patient was 
tolerating on day of discharge.  

 ID: The patient's fever curves were closely watched for signs 
of infection, of which there were none.  

 HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.  

 Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.  

 At the time of discharge, the patient was doing well, afebrile 
and hemodynamically stable. The patient was tolerating a 
bariatric stage 3 diet, ambulating, voiding without assistance, 
and pain was well controlled. The patient received discharge 
teaching and follow-up instructions with understanding 
verbalized and agreement with the discharge plan.  

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. MetFORMIN (Glucophage) 1000 mg PO QHS 
2. ped multivit #43-iron fumarate 18 mg iron oral DAILY 
3. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES DAILY 
4. Amitriptyline 50 mg PO QHS 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Moderate 
RX *acetaminophen 650 mg/20.3 mL 20.3 ml by mouth every six (6) 
hours Disp #*400 Milliliter Refills:*1 
2.  Docusate Sodium 100 mg PO BID 
please crush finely 
RX *docusate sodium 50 mg/5 mL 10 ml by mouth twice a day Disp 
#*200 Milliliter Refills:*0 
3.  OxycoDONE Liquid 5 mg PO Q4H:PRN Pain - Severe Duration: 5 
Days 
RX *oxycodone 5 mg/5 mL 5 ml by mouth every four (4) hours Disp 
___ Milliliter Refills:*0 
4.  Ranitidine (Liquid) 150 mg PO BID 
RX *ranitidine HCl 15 mg/mL 10 ml by mouth twice a day 
Refills:*0 
5.  Simethicone 40-80 mg PO QID:PRN gas pain 
RX *simethicone [Gas-X] 80 mg 1 tablet by mouth four times a day 
Disp #*40 Tablet Refills:*0 
6.  Amitriptyline 50 mg PO QHS  
7.  Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES DAILY  
8.  ped multivit #43-iron fumarate 18 mg iron oral DAILY  
9. HELD- MetFORMIN (Glucophage) 1000 mg PO QHS  This medication 
was held. Do not restart MetFORMIN (Glucophage) until you speak 
to your PCP

 
___:
Home
 
Discharge Diagnosis:
Morbid Obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Please call your surgeon or return to the emergency department 
if you develop a fever greater than 101.5, chest pain, shortness 
of breath, severe abdominal pain, pain unrelieved by your pain 
medication, severe nausea or vomiting, severe abdominal 
bloating, inability to eat or drink, foul smelling or colorful 
drainage from your incisions, redness or swelling around your 
incisions, or any other symptoms which are concerning to you.
  
 Diet: Stay on Stage III diet until your follow up appointment. 
Do not self advance diet, do not drink out of a straw or chew 
gum  
 Resume your home medications, CRUSH ALL PILLS.  

 You will be starting some new medications:  
 1. You are being discharged on medications to treat the pain  
 from your operation. These medications will make you drowsy and 
 
 impair your ability to drive a motor vehicle or operate  
 machinery safely. You MUST refrain from such activities while  
 taking these medications.  

 2. You should begin taking a chewable complete multivitamin 
with  
 minerals. No gummy vitamins.  

 3. You will be taking Zantac liquid ___ mg twice daily for one  

 month. This medicine prevents gastric reflux.  

 4. You should take a stool softener, Colace, twice daily for  
 constipation as needed, or until you resume a normal bowel  
 pattern.  

 5. You must not use NSAIDS (non-steroidal anti-inflammatory  
 drugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and  
 Naproxen. These agents will cause bleeding and ulcers in your  
 digestive system.  
 
 5. Follow up with your PCP before ___. 

 Activity:  
 No heavy lifting of items ___ pounds for 6 weeks. You may  
 resume moderate exercise at your discretion, no abdominal  
 exercises.  

 Wound Care:  
 You may shower, no tub baths or swimming.  
 If there is clear drainage from your incisions, cover with  
 clean, dry gauze.  

 Your steri-strips will fall off on their own. Please remove any 
 
 remaining strips ___ days after surgery.  
 Please call the doctor if you have increased pain, swelling,  
 redness, or drainage from the incision sites.  

 
Followup Instructions:
___